Insights & Research

Longevity & Regenerative Medicine Insights — Healthi Life Bangkok

Evidence-based insights on regenerative medicine, anti-aging therapies, and optimal health from Bangkok's leading longevity experts.

Featured Article

What a Physician-Led Longevity Program at Healthi Life Bangkok Actually Involves
Longevity Insights
Jul 23, 2026Healthi Life Editorial

What a Physician-Led Longevity Program at Healthi Life Bangkok Actually Involves

A look inside a physician-led longevity program at Healthi Life Bangkok — real diagnostics, real biomarkers, and Founding Ambassador Tim Kroeger's results.

Read Full Article

Latest Articles

Xeomin vs Botox: Formulation, Evidence and Choice
Longevity InsightsOct 31, 2026

Xeomin vs Botox: Formulation, Evidence and Choice

Xeomin vs Botox compared: protein load, immune response, diffusion and clinical evidence. Formulation differences that matter in 2026.

Healthi Life EditorialRead more
Botox Lip Flip: Evidence, Technique, and What to Expect
Longevity InsightsOct 30, 2026

Botox Lip Flip: Evidence, Technique, and What to Expect

The botox lip flip uses small doses of botulinum toxin to relax the upper lip muscle, creating subtle eversion. Evidence, technique, and cost.

Healthi Life EditorialRead more
MCHC Blood Test: Reference Ranges and What It Measures
Longevity InsightsOct 29, 2026

MCHC Blood Test: Reference Ranges and What It Measures

MCHC blood test measures hemoglobin concentration in red cells. Learn reference ranges, when MCHC is high or low, and what it means.

Healthi Life EditorialRead more
Retatrutide FDA Approval Status 2026: What We Know
Longevity InsightsOct 28, 2026

Retatrutide FDA Approval Status 2026: What We Know

Retatrutide FDA approval status 2026: investigational, Phase 3 TRIUMPH trials ongoing, not yet approved. Evidence-based review of timeline and data.

Healthi Life EditorialRead more
Mounjaro vs Wegovy: Medical Evidence and 2026 Outcomes
Longevity InsightsOct 27, 2026

Mounjaro vs Wegovy: Medical Evidence and 2026 Outcomes

Mounjaro vs Wegovy compared: mechanism, clinical evidence, metabolic outcomes, and what physicians consider before prescribing in 2026.

Healthi Life EditorialRead more
Muscle Mass After 40: What Changes and What to Do
Longevity InsightsOct 26, 2026

Muscle Mass After 40: What Changes and What to Do

Muscle mass after 40 declines 3–8% per decade without intervention. Learn what changes, which biomarkers to track, and how to preserve lean tissue.

Healthi Life EditorialRead more

Showing 6 of 133 articles

Explore Topics

This page is for general information and does not constitute medical advice, diagnosis, or treatment. Results vary between individuals. ⁨GLP-1 medication (semaglutide — Wegovy; tirzepatide — Mounjaro; retatrutide, investigational)⁩ is a prescription medicine, dispensed and administered only after assessment by a licensed physician. This page is medical information, not an advertisement or an offer of treatment. Every medicine and peptide listed here is dispensed only after a medical consultation at Healthi Life and on a physician's prescription. Prices are published for transparency, not as an offer to supply. Always consult a qualified physician about your condition. See our full medical disclaimer.